{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T15:13:12Z","timestamp":1785683592233,"version":"3.56.0"},"reference-count":79,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.det.2022.07.019","type":"journal-article","created":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T16:09:33Z","timestamp":1668787773000},"page":"209-229","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["A Practical Guide to the Diagnosis, Evaluation, and Treatment of Cutaneous T-Cell Lymphoma"],"prefix":"10.1016","volume":"41","author":[{"given":"Serena","family":"Shimshak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olayemi","family":"Sokumbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasro","family":"Isaq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amrita","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nneka","family":"Comfere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.det.2022.07.019_bib1","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.det.2015.06.001","article-title":"Evaluation, Diagnosis, and Staging of Cutaneous Lymphoma","volume":"33","author":"Olsen","year":"2015","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.det.2022.07.019_bib2","author":"National Comprehensive Cancer Network"},{"issue":"16","key":"10.1016\/j.det.2022.07.019_bib3","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2018-11-881268","article-title":"The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas","volume":"133","author":"Willemze","year":"2019","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.det.2022.07.019_bib5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.path.2014.02.003","article-title":"Mycosis Fungoides Variants","volume":"7","author":"Mart\u00ednez-Escala","year":"2014","journal-title":"Surg Pathol Clin"},{"issue":"7","key":"10.1016\/j.det.2022.07.019_bib6","doi-asserted-by":"crossref","DOI":"10.1097\/PAT.0000000000000166","article-title":"Mycosis fungoides with large cell transformation: clinicopathological features and prognostic factors","volume":"46","author":"Pulitzer","year":"2014","journal-title":"Pathology"},{"issue":"5","key":"10.1016\/j.det.2022.07.019_bib7","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.jaad.2007.06.004","article-title":"T-cell clonality analysis in biopsy specimens from two different skin sites shows high specificity in the diagnosis of patients with suggested mycosis fungoides","volume":"57","author":"Thurber","year":"2007","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"9","key":"10.1016\/j.det.2022.07.019_bib8","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/ajh.25577","article-title":"Mycosis fungoides and S\u00e9zary syndrome: 2019 update on diagnosis, risk-stratification, and management","volume":"94","author":"Hristov","year":"2019","journal-title":"Am J Hematol"},{"issue":"11","key":"10.1016\/j.det.2022.07.019_bib9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11864-021-00899-0","article-title":"How to Sequence Therapies in Mycosis Fungoides","volume":"22","author":"Brumfiel","year":"2021","journal-title":"Curr Treat Options Oncol"},{"issue":"2","key":"10.1016\/j.det.2022.07.019_bib10","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s11864-020-00809-w","article-title":"Mycosis Fungoides and S\u00e9zary Syndrome: Updates and Review of Current Therapy","volume":"22","author":"Kamijo","year":"2021","journal-title":"Curr Treat Options Oncol"},{"issue":"1","key":"10.1016\/j.det.2022.07.019_bib11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jaad.2015.09.033","article-title":"Guidelines for phototherapy of mycosis fungoides and S\u00e9zary syndrome: A consensus statement of the United States Cutaneous Lymphoma Consortium","volume":"74","author":"Olsen","year":"2016","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.det.2022.07.019_bib12","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.jaad.2019.07.040","article-title":"Skin-directed radiation therapy for cutaneous lymphoma: The Mayo Clinic experience","volume":"82","author":"King","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.det.2022.07.019_bib13","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jaad.2020.01.046","article-title":"A\u00a0prospective cohort study of condensed low-dose total skin electron beam therapy for mycosis fungoides: Reduction of disease burden and improvement in quality of life","volume":"83","author":"Song","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.det.2022.07.019_bib14","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s11912-018-0678-x","article-title":"Systemic Treatment Options for Advanced-Stage Mycosis Fungoides and S\u00e9zary Syndrome","volume":"20","author":"Photiou","year":"2018","journal-title":"Curr Oncol Rep"},{"issue":"21","key":"10.1016\/j.det.2022.07.019_bib15","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1182\/blood.V124.21.1673.1673","article-title":"Prognostic Factors, Staging and Treatments in Advanced Stage Mycosis Fungoides and S\u00e9zary Syndrome","volume":"124","author":"Talpur","year":"2014","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.det.2022.07.019_bib16","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jaad.2017.04.1137","article-title":"Racial disparity in mycosis fungoides: An analysis of 4495 cases from the US National Cancer Database","volume":"77","author":"Su","year":"2017","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.det.2022.07.019_bib17","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.jaad.2011.12.021","article-title":"Pruritus in cutaneous T-cell lymphoma: A review","volume":"67","author":"Ahern","year":"2012","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.det.2022.07.019_bib18","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.det.2022.07.019_bib19","doi-asserted-by":"crossref","DOI":"10.1001\/archderm.1968.01610070029004","article-title":"Lymphomatoid papulosis. A continuing self-healing eruption, clinically benign--histologically malignant","volume":"97","author":"Macaulay","year":"1968","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.det.2022.07.019_bib20","doi-asserted-by":"crossref","DOI":"10.1111\/jdv.15931","article-title":"Lymphomatoid papulosis: an update and review","volume":"34","author":"Martinez-Cabriales","year":"2020","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.det.2022.07.019_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.det.2019.05.005","article-title":"Lymphomatoid Papulosis and Other Lymphoma-Like Diseases","volume":"37","author":"Moy","year":"2019","journal-title":"Dermatol Clin"},{"issue":"4","key":"10.1016\/j.det.2022.07.019_bib22","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s40257-016-0192-6","article-title":"Lymphomatoid Papulosis in Children and Adolescents: A Systematic Review","volume":"17","author":"Wieser","year":"2016","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"10.1016\/j.det.2022.07.019_bib23","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1634\/theoncologist.2015-0242","article-title":"Frequency and Risk Factors for Associated Lymphomas in Patients With Lymphomatoid Papulosis","volume":"21","author":"Cordel","year":"2016","journal-title":"Oncologist"},{"issue":"2","key":"10.1016\/j.det.2022.07.019_bib24","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/jdv.16065","article-title":"Frequency and prognosis of associated malignancies in 504 patients with lymphomatoid papulosis","volume":"34","author":"Melchers","year":"2020","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.det.2022.07.019_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2021.04.081","article-title":"Primary cutaneous T-cell lymphomas other than Mycosis Fungoides and Sezary Syndrome \u2013 Part II: Prognosis and Management","author":"Oh","year":"2021","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.det.2022.07.019_bib26","doi-asserted-by":"crossref","DOI":"10.1111\/cup.12446","article-title":"ALK-positive (2p23 rearranged) anaplastic large cell lymphoma with localization to the skin in a pediatric patient","volume":"42","author":"Pulitzer","year":"2015","journal-title":"J\u00a0Cutan Pathol"},{"issue":"6","key":"10.1016\/j.det.2022.07.019_bib27","doi-asserted-by":"crossref","DOI":"10.1111\/cup.12937","article-title":"Primary cutaneous anaplastic large cell lymphoma","volume":"44","author":"Brown","year":"2017","journal-title":"J\u00a0Cutan Pathol"},{"issue":"15","key":"10.1016\/j.det.2022.07.019_bib28","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2011-05-351346","article-title":"EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma","volume":"118","author":"Kempf","year":"2011","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.det.2022.07.019_bib29","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/jdv.16006","article-title":"Prognostic factors in patients with primary cutaneous anaplastic large cell lymphoma: a multicentric, retrospective analysis of the Spanish Group of Cutaneous Lymphoma","volume":"34","author":"Fern\u00e1ndez-de-Misa","year":"2020","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"5","key":"10.1016\/j.det.2022.07.019_bib30","doi-asserted-by":"crossref","DOI":"10.1097\/PAS.0b013e3182487158","article-title":"Nodal involvement by cutaneous CD30-positive T-cell lymphoma mimicking classical Hodgkin lymphoma","volume":"36","author":"Eberle","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.det.2022.07.019_bib31","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/modpathol.2010.225","article-title":"Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsies","volume":"24","author":"Wada","year":"2011","journal-title":"Mod Pathol"},{"issue":"9","key":"10.1016\/j.det.2022.07.019_bib32","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1182\/blood-2014-04-571091","article-title":"ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes","volume":"124","author":"Parrilla Castellar","year":"2014","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.det.2022.07.019_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/jid.2009.314","article-title":"IRF4 gene rearrangements define a subgroup of CD30-positive cutaneous T-cell lymphoma: a study of 54 cases","volume":"130","author":"Pham-Ledard","year":"2010","journal-title":"J\u00a0Invest Dermatol"},{"issue":"1","key":"10.1016\/j.det.2022.07.019_bib34","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00000478-199101000-00002","article-title":"T-cell lymphoma involving subcutaneous tissue. A clinicopathologic entity commonly associated with hemophagocytic syndrome","volume":"15","author":"Gonzalez","year":"1991","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.det.2022.07.019_bib35","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/bjd.17985","article-title":"Epidemiology of primary cutaneous \u03b3\u03b4 T-cell lymphoma and subcutaneous panniculitis-like T-cell lymphoma in the U.S.A. from 2006 to 2015: a Surveillance, Epidemiology, and End Results-18 analysis","volume":"181","author":"Goyal","year":"2019","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.det.2022.07.019_bib36","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2007-04-087288","article-title":"Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases","volume":"111","author":"Willemze","year":"2008","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.det.2022.07.019_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2018.05.1243","article-title":"Subcutaneous panniculitis-like T-cell lymphoma: Clinical features, therapeutic approach, and outcome in a case series of 16 patients","volume":"79","author":"L\u00f3pez-Lerma","year":"2018","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2022.07.019_bib38","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow","year":"2008"},{"issue":"7","key":"10.1016\/j.det.2022.07.019_bib39","doi-asserted-by":"crossref","DOI":"10.1111\/cas.12439","article-title":"Clinicopathological analysis of 17 primary cutaneous T-cell lymphoma of the \u03b3\u03b4 phenotype from Japan","volume":"105","author":"Takahashi","year":"2014","journal-title":"Cancer Sci"},{"issue":"3","key":"10.1016\/j.det.2022.07.019_bib40","doi-asserted-by":"crossref","DOI":"10.1097\/PAS.0b013e318275d1a2","article-title":"TCR-\u03b3 expression in primary cutaneous T-cell lymphomas","volume":"37","author":"Rodr\u00edguez-Pinilla","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.det.2022.07.019_bib41","doi-asserted-by":"crossref","DOI":"10.1111\/ejh.12439","article-title":"Gamma-delta t-cell lymphomas","volume":"94","author":"Foppoli","year":"2015","journal-title":"Eur J Haematol"},{"issue":"1","key":"10.1016\/j.det.2022.07.019_bib42","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1038\/s41467-020-15572-7","article-title":"Cellular origins and genetic landscape of cutaneous gamma delta T cell lymphomas","volume":"11","author":"Daniels","year":"2020","journal-title":"Nat Commun"},{"issue":"12","key":"10.1016\/j.det.2022.07.019_bib43","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1111\/cup.14082","article-title":"The significance of epidermal involvement in primary cutaneous gamma\/delta (\u03b3\u03b4) T-cell lymphoma: A systematic review and meta-analysis","volume":"48","author":"Goyal","year":"2021","journal-title":"J\u00a0Cutan Pathol"},{"issue":"9","key":"10.1016\/j.det.2022.07.019_bib44","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1182\/blood-2002-05-1597","article-title":"Gamma-delta T-cell phenotype is associated with significantly decreased survival in cutaneous T-cell lymphoma","volume":"101","author":"Toro","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.det.2022.07.019_bib45","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms7025","article-title":"Activating mutations of STAT5B and STAT3 in lymphomas derived from \u03b3\u03b4-T or NK cells","volume":"6","author":"K\u00fc\u00e7\u00fck","year":"2015","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.det.2022.07.019_bib46","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/PAS.0000000000000768","article-title":"Primary Cutaneous T-Cell Lymphomas Showing Gamma-Delta (\u03b3\u03b4) Phenotype and Predominantly Epidermotropic Pattern are Clinicopathologically Distinct From Classic Primary Cutaneous \u03b3\u03b4 T-Cell Lymphomas","volume":"41","author":"Merrill","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"23","key":"10.1016\/j.det.2022.07.019_bib47","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2017-12-791418","article-title":"Advances in the treatment of extranodal NK\/T-cell lymphoma, nasal type","volume":"131","author":"Yamaguchi","year":"2018","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.det.2022.07.019_bib48","doi-asserted-by":"crossref","DOI":"10.1200\/JOP.18.00719","article-title":"Management of NK\/T-Cell Lymphoma, Nasal Type","volume":"15","author":"Allen","year":"2019","journal-title":"J\u00a0Oncol Pract"},{"issue":"6","key":"10.1016\/j.det.2022.07.019_bib49","doi-asserted-by":"crossref","DOI":"10.1007\/s11899-016-0355-9","article-title":"Extranodal NK\/T Cell Lymphoma, Nasal Type (ENKTL-NT): An Update on Epidemiology, Clinical Presentation, and Natural History in North American and European Cases","volume":"11","author":"Haverkos","year":"2016","journal-title":"Curr Hematol Malig Rep"},{"issue":"3","key":"10.1016\/j.det.2022.07.019_bib50","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.beha.2019.06.005","article-title":"NK\/T-cell lymphomas","volume":"32","author":"Tse","year":"2019","journal-title":"Best Pract Res Clin Haematol"},{"issue":"12","key":"10.1016\/j.det.2022.07.019_bib51","article-title":"EBV-associated cutaneous NK\/T-cell lymphoma: review of a series of 14 cases from peru in children and young adults","volume":"34","author":"Rodr\u00edguez-Pinilla","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.det.2022.07.019_bib52","series-title":"Extranodal NK\/T cell lymphoma, nasal type WHO classification of tumours of haematopoietic and lymphoid Tissues","first-page":"368","author":"Chan","year":"2017"},{"issue":"2","key":"10.1016\/j.det.2022.07.019_bib53","doi-asserted-by":"crossref","first-page":"123","DOI":"10.6004\/jnccn.2018.0007","article-title":"NCCN Guidelines Insights: T-Cell Lymphomas, Version 2.2018","volume":"16","author":"Horwitz","year":"2018","journal-title":"J\u00a0Natl Compr Canc Netw"},{"issue":"7","key":"10.1016\/j.det.2022.07.019_bib54","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/bmt.2014.65","article-title":"Allogeneic haematopoietic SCT for natural killer\/T-cell lymphoma: a multicentre analysis from the Asia Lymphoma Study Group","volume":"49","author":"Tse","year":"2014","journal-title":"Bone Marrow Transpl"},{"issue":"5","key":"10.1016\/j.det.2022.07.019_bib55","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.jaad.2020.08.109","article-title":"Localization patterns and survival of extranodal natural killer\/T-cell lymphomas in the United States: A population-based study of 945 cases","volume":"85","author":"Goyal","year":"2021","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.det.2022.07.019_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2016.06.011","article-title":"Cutaneous peripheral T-cell lymphoma, not otherwise specified: A single-center prognostic analysis","volume":"75","author":"Tolkachjov","year":"2016","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.det.2022.07.019_bib57","doi-asserted-by":"crossref","DOI":"10.1111\/jdv.16969","article-title":"Primary cutaneous peripheral T-cell lymphoma, not otherwise specified: results of a multicentre European Organization for Research and Treatment of Cancer (EORTC) cutaneous lymphoma taskforce study on the clinico-pathological and prognostic features","volume":"35","author":"Kempf","year":"2021","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"5","key":"10.1016\/j.det.2022.07.019_bib58","doi-asserted-by":"crossref","DOI":"10.1111\/cup.13967","article-title":"Post-transplant primary cutaneous peripheral T-cell lymphoma not otherwise specified in a pediatric patient","volume":"48","author":"Cardwell","year":"2021","journal-title":"J\u00a0Cutan Pathol"},{"issue":"4","key":"10.1016\/j.det.2022.07.019_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.det.2019.05.007","article-title":"Cutaneous T Cell Lymphoma: A Difficult Diagnosis Demystified","volume":"37","author":"Peterson","year":"2019","journal-title":"Dermatol Clin"},{"issue":"4","key":"10.1016\/j.det.2022.07.019_bib60","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2559.2010.03498.x","article-title":"Primary cutaneous follicular variant of peripheral T-cell lymphoma NOS. A report of two cases","volume":"56","author":"le Tourneau","year":"2010","journal-title":"Histopathology"},{"issue":"3","key":"10.1016\/j.det.2022.07.019_bib61","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1182\/blood.V50.3.481.481","article-title":"Adult T-cell leukemia: clinical and hematologic features of 16 cases","volume":"50","author":"Uchiyama","year":"1977","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.det.2022.07.019_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2019.11.034","article-title":"Improved survival for skin-primary presentation of adult T-cell leukemia\/lymphoma (ATLL)","volume":"83","author":"Jain","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"15","key":"10.1016\/j.det.2022.07.019_bib63","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2010-11-316794","article-title":"Type of skin eruption is an independent prognostic indicator for adult T-cell leukemia\/lymphoma","volume":"117","author":"Sawada","year":"2011","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.det.2022.07.019_bib64","doi-asserted-by":"crossref","DOI":"10.1053\/j.semdp.2019.07.010","article-title":"Cutaneous manifestations of adult T-cell leukemia\/lymphoma","volume":"37","author":"Miyashiro","year":"2020","journal-title":"Semin Diagn Pathol"},{"issue":"9","key":"10.1016\/j.det.2022.07.019_bib65","doi-asserted-by":"crossref","DOI":"10.1111\/cup.13789","article-title":"Adult T-cell leukemia\/lymphoma clinically confused with viral\/drug skin eruptions and pathologically misinterpreted as mycosis fungoides\/S\u00e9zary syndrome","volume":"48","author":"AbdullGaffar","year":"2021","journal-title":"J\u00a0Cutan Pathol"},{"key":"10.1016\/j.det.2022.07.019_bib66","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.coviro.2015.09.004","article-title":"How does HTLV-1 cause adult T-cell leukaemia\/lymphoma (ATL)?","volume":"14","author":"Bangham","year":"2015","journal-title":"Curr Opin Virol"},{"issue":"2","key":"10.1016\/j.det.2022.07.019_bib67","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jaad.2014.10.006","article-title":"Cutaneous manifestations of human T-cell lymphotrophic virus type-1-associated adult T-cell leukemia\/lymphoma: a single-center, retrospective study","volume":"72","author":"Marchetti","year":"2015","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"34","key":"10.1016\/j.det.2022.07.019_bib68","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2016.67.7732","article-title":"Multicenter Phase II Study of Lenalidomide in Relapsed or Recurrent Adult T-Cell Leukemia\/Lymphoma: ATLL-002","volume":"34","author":"Ishida","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"issue":"26","key":"10.1016\/j.det.2022.07.019_bib69","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2009-03-211821","article-title":"Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia\/lymphoma (ATL)","volume":"113","author":"Kchour","year":"2009","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.det.2022.07.019_bib70","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1200\/JCO.18.00501","article-title":"Revised Adult T-Cell Leukemia-Lymphoma International Consensus Meeting Report","volume":"37","author":"Cook","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.det.2022.07.019_bib71","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.3389\/fonc.2019.01558","article-title":"An Update on Molecular Biology of Cutaneous T Cell Lymphoma","volume":"9","author":"Walia","year":"2019","journal-title":"Front Oncol"},{"issue":"9","key":"10.1016\/j.det.2022.07.019_bib72","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/ng.3356","article-title":"Genomic landscape of cutaneous T cell lymphoma","volume":"47","author":"Choi","year":"2015","journal-title":"Nat Genet"},{"issue":"9","key":"10.1016\/j.det.2022.07.019_bib73","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/ng.3370","article-title":"Genomic analysis of mycosis fungoides and S\u00e9zary syndrome identifies recurrent alterations in TNFR2","volume":"47","author":"Ungewickell","year":"2015","journal-title":"Nat Genet"},{"issue":"11","key":"10.1016\/j.det.2022.07.019_bib74","doi-asserted-by":"crossref","first-page":"e450","DOI":"10.3324\/haematol.2015.132837","article-title":"Mutated JAK kinases and deregulated STAT activity are potential therapeutic targets in cutaneous T-cell lymphoma","volume":"100","author":"P\u00e9rez","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.det.2022.07.019_bib75","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.00514","article-title":"New Insights Into the Complex Mutational Landscape of S\u00e9zary Syndrome","volume":"10","author":"Mirza","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.det.2022.07.019_bib76","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.00765","article-title":"Update on Biology of Cutaneous T-Cell Lymphoma","volume":"10","author":"Phyo","year":"2020","journal-title":"Front Oncol"},{"issue":"9","key":"10.1016\/j.det.2022.07.019_bib77","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1080\/10428194.2021.1901098","article-title":"Subcutaneous panniculitis-like T-cell lymphoma, lupus erythematosus profundus, and overlapping cases: molecular characterization through the study of 208 genes","volume":"62","author":"Machan","year":"2021","journal-title":"Leuk Lymphoma"},{"issue":"12","key":"10.1016\/j.det.2022.07.019_bib78","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1038\/s41588-018-0251-4","article-title":"Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome","volume":"50","author":"Gayden","year":"2018","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.det.2022.07.019_bib79","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1182\/bloodadvances.2018028340","article-title":"Frequent germline mutations of HAVCR2 in sporadic subcutaneous panniculitis-like T-cell lymphoma","volume":"3","author":"Polprasert","year":"2019","journal-title":"Blood Adv"},{"issue":"13","key":"10.1016\/j.det.2022.07.019_bib80","first-page":"1058","article-title":"HAVCR2 mutations are associated with severe hemophagocytic syndrome in subcutaneous panniculitis-like T-cell lymphoma","volume":"135","author":"Sonigo","year":"2020","journal-title":"Blood"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863522000717?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863522000717?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:48:09Z","timestamp":1760006889000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733863522000717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":79,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S0733863522000717"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2022.07.019","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Practical Guide to the Diagnosis, Evaluation, and Treatment of Cutaneous T-Cell Lymphoma","name":"articletitle","label":"Article Title"},{"value":"Dermatologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.det.2022.07.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}